Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval ·

FDA Issues Emergency Use Authorization for Drug to Treat New World Screwworm in Dogs and Puppies

View source ↗

Summary

FDA issued an Emergency Use Authorization for Simparica TRIO to treat New World screwworm infestations in dogs and puppies.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Simparica TRIO (sarolaner, moxidectin, and pyrantel)

Snippet

The U.S. Food and Drug Administration today issued an Emergency Use Authorization (EUA) for Simparica TRIO (sarolaner, moxidectin, and pyrantel chewable tablets) for the treatment of New World screwworm (NWS) infestations (myiasis) in dogs and puppies.